Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial to Determine the Efficacy of Ketamine as an Adjunct for Pain Management in Patients With Sickle Cell Crisis

NCT03502421 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.

NCT NCT03502421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03502421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial to Determine the Efficacy of Ketamine as an Adjunct for Pain Management in Patients With Sickle Cell Crisis
Lead sponsor
University of South Florida
Phase
Phase 3
Overall status
Withdrawn
Start date
September 1, 2018
Completion date
November 1, 2019
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pain, chronic, sc disease